<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report results of a clinico-physiological study of the efficacy of a vasoactive agent sermion in patients with initial atherosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> indicating a positive effect of course treatment with this agent on the main clinical manifestations of the disease, pulse blood filling, bioelectric activity of the brain, psychomotor rate, mental working capacity, mnemonic function </plain></SENT>
<SENT sid="1" pm="."><plain>Considering the established age-related differences in the efficacy of the agent, it is expedient to recommend sermion for long-term employment in the elderly </plain></SENT>
<SENT sid="2" pm="."><plain>One should be cautious in instituting the drug in persons suffering of raised intraocular pressure </plain></SENT>
</text></document>